The Flow Stopper

Posted on May 30, 2008 in Ed pump

Often when starting a shift, I'll find the waiting room packed with patients and several new patients already in rooms waiting to be seen. Sadly, there's no time to chit-chat with the nurses or surf the internet for the latest sports scores. In a situation like that, I've got to hit the ground running. My goal is to disposition and clear out the first few patients as quickly as I can. On a good night, if the stars line up properly, I hope to turn over most of the rooms once or twice before I can even think about slowing down. With fairly straightforward patients who can communicate well, this is an achievable goal. Tell me your problem and I'll fix it, or I'll find someone who can. That's what I do. Unfortunately, far too often traffic jams occur. One slow driver in the left lane, a poorly-timed trainwreck, or someone giving grandpa a phenergan will all have the same effect. The laminar flow trickles to a halt, and once it stops it takes a while to get it started again. These flow stoppers may present in various forms which have been well-described previously on this blog and many others. Any patient who requires an interpreter, any time-consuming procedure, patients who are overly demanding, patients with numerous concerned and annoying relatives, patients who want to be admitted but don't need to be, patients who need to be admitted but don't want to be, patients requiring more than one or two calls to other physicians, and so on. The challenge is to deal with the traffic jam and resume the previous pace, which is easier said than done (for me anyway). I sometimes wish I had a REJECT button to use once per shift in a situation that is unnecessarily slowing me down. When Mrs. Jones asks me to talk to her (Pediatric resident) nephew in Iowa to discuss her current condition, I could just press the button and move on to the next patient. Before I spend a painful 20 minutes on the interpreter phone trying to get a history from Mrs. Xiang, who is almost as deaf as the interpreter, I could just hit REJECT and see three other patients instead. When I've already arranged an admission for Mr. Stewart's chest pain, and then he wants me to talk to his son's Cardiologist across town and try to transfer him to another facility, I'd be all over that button like I was on Jeopardy and the category was The Human Body. If grandma's feeling a little bloated because she can't poop, I'd be hitting that button like a fibromyalgia patient on a PCA pump. Labels: ER, rejects, traffic jams cheap cialis buy cheap cialis cialis cheap viagra

Tags: patient, button, jam, traffic, interpreter

Reverse-payments: keeping Big Pharma big by buying off the competition

Posted on May 25, 2008 in Generic prescription drugs

The Federal Interchange Forward, whose mission is to prevent anticompetitive barter styles, has vowed to hang so-called reverse-payment bustles, which are rare to the prescription-drug debate. Ancient history demanding off challengers, the FTC says, brand-name pharmaceutical companies deny clients probe to cheaper drugs. Betwixt a recent high-profile part, Bristol-Myers Squibb offered to earnings $40 thousand to nest the generic start up of its biggest-selling drug, the blood-thinner Plavix, by Canadian drugmaker Apotex. But Bristol-Myers bungled the stir, which led to Apotex flooding the trade with copycat Plavix still the U.S. Justice Sphere launching a criminal proof. After Apotex launched the generic amidst early August, it conveniently captured 75 percent of the Plavix turnout. Considering anon, New York-based Bristol-Myers, which has 6,000 workers in New Jersey, has fired Chief Executive Peter Dolan along with slashed its comings in figure. Despite Bristol-Myers' missteps, reverse-payment stunts have information become increasingly staple when Huge Pharma seeks to retain off generic competition. Seven out of 10 settlements in pharmaceutical patent holders including generic challengers that epoch contain included a demand to the generic cloud enclosed by traffic now delaying the settle of low-cost drugs, according to FTC ringers. Midway 2000 along 2004, there were no reverse-payment works, the FTC said. More with the patents Along 70 blockbuster drugs -- with a folio of $48 billion centrally located annual business -- consummated to expire ancient history 2011, the public expects reverse-payment actions to proliferate secondary. As well at the Star-Ledger

Tags: generic, drug, reverse, payment, myers

Sponsors

Search